Who
Juan Sanchez
Director
Company insider
Files Form 4 as: Director, Nuvectis Pharma.
In numbers
- Trades disclosed
- 4
- Buys
- 1
- Sells
- 0
- Bought
- $75K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 22 Sep 2025
- Last trade
- 11 Jun 2026
- Last filed
- 12 Jun 2026
Companies traded
Activity over time
1 Nov 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 11 Jun 2026filed 12 Jun 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 11 Jun 2026filed 12 Jun 2026 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
| 5 Nov 2025filed 6 Nov 2025 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Bought | $75K13,000 at $5.79 | filing |
| 22 Sep 2025filed 31 Oct 2025 | NVCT Nuvectis PharmaBiotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
News
Juan Sanchez, Author at HousingWirehousingwire.com · 12 Oct 2026Baunfire CEO Juan Sanchez Speaks on Agency Growth in the AI Era at Webflow Conf 2026owensoundsuntimes.com · 30 Sep 2026DesignRush: Baunfire CEO Juan Sanchez Speaks on Agency Growth in the AI Era at Webflow Conf 2026finanznachrichten.de · 30 Sep 2026Nuvectis Pharma (NASDAQ:NVCT) Stock Falls 6.8% – Here's WhyNVCT · themarketsdaily.com · 15 Oct 2026
3 headlines in the last 90 days name Juan Sanchez; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.